LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - CRISPR Therapeutics (NASDAQ: CRSP)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CRSP CRISPR Therapeutics
Kulkarni Samarth / director, officer: Chief Executive Officer
10/17/2025
Sell
$67.91
50,895
$3.456M
254,201
NASDAQ CRSP CRISPR Therapeutics
Kulkarni Samarth / director, officer: Chief Executive Officer
10/14/2025
Sell
$66.60
4,242
$283K
205,096
NASDAQ CRSP CRISPR Therapeutics
KASINGER JAMES R. / officer: General Counsel and Secretary
10/14/2025
Sell
$66.60
1,076
$72K
83,402
NASDAQ CRSP CRISPR Therapeutics
Kulkarni Samarth / director, officer: Chief Executive Officer
10/03/2025
Buy
$67.74
49,500
$3.353M
49,500
NASDAQ CRSP CRISPR Therapeutics
Patel Naimish / officer: Chief Medical Officer
10/03/2025
Buy
$67.74
16,500
$1.118M
16,500
NASDAQ CRSP CRISPR Therapeutics
KASINGER JAMES R. / officer: General Counsel and Secretary
10/03/2025
Buy
$67.74
16,500
$1.118M
16,500
NASDAQ CRSP CRISPR Therapeutics
Prasad Raju / officer: Chief Financial Officer
10/03/2025
Buy
$67.74
16,500
$1.118M
16,500